Left ventricular (LV) remodeling and hypertrophy occurs frequently in the general population and is a strong predictor of myocardial infarction, heart failure, and stroke. Data previously collected in the HyperGEN and GENOA studies of the Family Blood Pressure Program (FBPP) have pointed to genetic loci contributing to LV hypertrophy and dimensional traits through linkage studies and genome-wide association studies. Despite these advances, a large portion of variation in LV traits is unaccounted for. We hypothesize that, in part, rare variants account for this variation. We propose the following aims.
Aim 1. Whole exome sequence (WES) 1,200 AA unrelated hypertensives with extreme values for echocardiographic LV mass/hgt2.7 to identify rare and low-frequency variants contributing to LV mass and related structural and functional phenotypes. We will select unrelated individuals from the top and bottom quartile of LV mass index. Because the distribution of LV mass/hgt2.7 in the FBPP is shifted to higher values than the general population, the cutpoint for the upper quartile is approximately equal to the definition of LVH. We will sequence at a density sufficient to capture rare variants. We will conduct extreme phenotype-based analysis, weighted by function and conservation, to identify high-impact coding variants. A gene list will be ranked for selection in Aim 2 based on evidence from statistical and bioinformatic analyses and expression experiments in induced pluripotent stem cell- (iPSC-)derived cardiomyocytes.
Aim 2. Validate variants detected in Aim 1 by resequencing 40 candidate genes in all AA HyperGEN/GENOA family members, and subsequently validate 768 most significant variants in external cohorts. We will sequence all exons and regulatory regions in the remainder of the FBPP families and siblings not sequenced in Aim 1 (n=2,266). We will conduct association analysis followed by bioinformatic filtering to identify high-impact coding variants and rank the 768 most significant variants for further external replication. We will genotype these in 9,160 AA (5,623 hypertensive) participants from population-based studies using Illumina assays (ie, JHS, CARDIA, ARIC, CHS, WUSTL). Gene-based associations will be examined within and meta-analyzed among cohorts. Genes will be ranked by statistical and biological evidence to move to Aim 3.
Aim 3. Use human iPSC cardiomyocytes to functionally validate variants replicated in Aim 2. Using hypertrophy-induced cardiomyocytes, we will test the direction of effect and clinical characterization of associated genes with rare variants from Aim 2. We will use siRNA transfections to test whether knock down of candidate genes influences hypertrophy in the cell-based model. The research proposed herein, if successful, will continue the success of HyperGEN and GENOA in identifying novel genes contributing to LV hypertrophy, and evaluate their relevance in a cell-based system to identify new pathways for future treatment.

Public Health Relevance

Black people tend to have an enlarged left ventricle (the heart chamber that pumps oxygenated blood throughout the body) more commonly than those in other race groups, putting them at greater risk for having potentially fatal cardiovascular diseases. Enlarged left ventricles are caused, at least in part, by a person's genes. This study seeks to discover which genetic factors may cause an enlarged heart;this may ultimately lead to new diagnoses and treatments to help lower cardiovascular disease risk in blacks.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL055673-17
Application #
8665454
Study Section
Special Emphasis Panel (ZRG1-PSE-H (02))
Program Officer
Jaquish, Cashell E
Project Start
1996-08-10
Project End
2017-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
17
Fiscal Year
2014
Total Cost
$1,179,645
Indirect Cost
$126,866
Name
University of Alabama Birmingham
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Taylor, Jacquelyn Y; Schwander, Karen; Kardia, Sharon L R et al. (2016) A Genome-wide study of blood pressure in African Americans accounting for gene-smoking interaction. Sci Rep 6:18812
Olfson, E; Saccone, N L; Johnson, E O et al. (2016) Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans. Mol Psychiatry 21:601-7
Liu, Ching-Ti; Raghavan, Sridharan; Maruthur, Nisa et al. (2016) Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin. Am J Hum Genet 99:56-75
Mangino, Massimo; Christiansen, Lene; Stone, Rivka et al. (2015) DCAF4, a novel gene associated with leucocyte telomere length. J Med Genet 52:157-62
de Simone, Giovanni; Roman, Mary J; De Marco, Marina et al. (2015) Hemodynamic Correlates of Abnormal Aortic Root Dimension in an Adult Population: The Strong Heart Study. J Am Heart Assoc 4:e002309
Sung, Yun Ju; Basson, Jacob; Cheng, Nuo et al. (2015) The role of rare variants in systolic blood pressure: analysis of ExomeChip data in HyperGEN African Americans. Hum Hered 79:20-7
Sung, Yun Ju; Schwander, Karen; Arnett, Donna K et al. (2014) An empirical comparison of meta-analysis and mega-analysis of individual participant data for identifying gene-environment interactions. Genet Epidemiol 38:369-78
Simino, Jeannette; Kume, Rezart; Kraja, Aldi T et al. (2014) Linkage analysis incorporating gene-age interactions identifies seven novel lipid loci: the Family Blood Pressure Program. Atherosclerosis 235:84-93
Glasser, Stephen P; Lynch, Amy I; Devereux, Richard B et al. (2014) Hemodynamic and echocardiographic profiles in African American compared with White offspring of hypertensive parents: the HyperGEN study. Am J Hypertens 27:21-6
de Simone, G; Arnett, D K; Chinali, M et al. (2013) Partial normalization of components of metabolic syndrome does not influence prevalent echocardiographic abnormalities: the HyperGEN study. Nutr Metab Cardiovasc Dis 23:38-45

Showing the most recent 10 out of 72 publications